{"product_id":"reckitt-marketing-mix","title":"Reckitt Benckiser Group Marketing Mix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eYour Shortcut to a Strategic 4Ps Breakdown\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eReckitt Benckiser’s 4P mix blends strong product innovation in health and hygiene with premium and value-tier pricing, extensive global distribution, and impactful digital-forward promotions—driving brand trust and market share; the preview highlights key tactics, but the full 4Ps report unlocks detailed data, ready-to-use slides, and strategic recommendations to apply immediately.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eroduct\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDiversified Portfolio of Powerbrands\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eReckitt maintains a diversified portfolio of powerbrands across health, hygiene, and nutrition—Lysol, Dettol, and Nurofen lead global shares; in 2024 Reckitt reported £12.9bn revenue with core health \u0026amp; hygiene driving ~68% of sales.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eScience-Led Innovation and R\u0026amp;D\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eReckitt’s product strategy anchors on rigorous R\u0026amp;D, spending 1.2 billion USD in 2024 on science-led programs to drive superior efficacy and clinical differentiation.\u003c\/p\u003e\n\u003cp\u003eBy end-2025 Reckitt integrated advanced biotech and clinical insights to launch five specialized health solutions, boosting its Rx-adjacent portfolio and widening gross margins by ~220 basis points vs. 2022.\u003c\/p\u003e\n\u003cp\u003eThis science-focus lets Reckitt justify premium pricing, sustain a top-market share in hygiene and health segments, and attract health-conscious consumers seeking clinically validated benefits.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSustainable and Eco-Friendly Packaging\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eReckitt has shifted major lines like Finish and Vanish to recyclable or reusable packaging, cutting virgin plastic use by 20% across EU SKUs in 2024 and targeting 50% recycled content by 2030.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExpansion into Preventative Healthcare\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eReckitt has shifted from reactive treatments to preventative healthcare, expanding vitamins, minerals and supplements under trusted brands like Schiff and Nurofen, targeting the $160B global supplements market (2024) to boost daily-use penetration.\u003c\/p\u003e\n\u003cp\u003eIn 2024 Reckitt reported 3% organic sales growth in Health, driven partly by supplements; this strategy aims to lift household repeat purchase rates and margin by moving sales into higher-frequency wellness routines.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eTargets $160B supplements market (2024)\u003c\/li\u003e\n\u003cli\u003e3% organic Health sales growth in 2024\u003c\/li\u003e\n\u003cli\u003eFocus on daily-use, higher-margin SKUs\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInfant and Adult Nutrition Specialization\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe nutrition segment is a core pillar, offering specialized infant formulas and adult nutrition for aging populations, driving 2024 net revenue of £4.1bn for RB Health (Reckitt Benckiser Group) and steady mid-single-digit organic growth.\u003c\/p\u003e\n\u003cp\u003eBrands like Enfamil deliver science-backed formulas targeting allergies and complex needs, supporting higher ASPs and loyalty—RB reports double-digit market-share positions in key markets (US, China) and gross margins ~58% in nutrition lines.\u003c\/p\u003e\n\u003cp\u003eSpecialization creates high entry barriers via clinical trials, regulatory approvals, and supply-chain scale, reducing churn and enabling recurring sales from long product life cycles.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 RB Health revenue £4.1bn\u003c\/li\u003e\n\u003cli\u003eNutrition gross margin ~58%\u003c\/li\u003e\n\u003cli\u003eMid-single-digit organic growth (2024)\u003c\/li\u003e\n\u003cli\u003eDouble-digit market share in US\/China\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eReckitt: £12.9bn science-led group, £4.1bn RB Health, £1.2bn R\u0026amp;D, 5 biotech launches\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eReckitt’s product mix centers on science-led health, hygiene, and nutrition powerbrands (Lysol, Dettol, Nurofen, Enfamil), £12.9bn group revenue in 2024, RB Health £4.1bn, 1.2bn USD R\u0026amp;D (2024), 3% organic Health growth (2024), nutrition gross margin ~58%, 20% EU virgin plastic cut (2024), five biotech launches by 2025.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eGroup revenue 2024\u003c\/td\u003e\n\u003ctd\u003e£12.9bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRB Health 2024\u003c\/td\u003e\n\u003ctd\u003e£4.1bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D 2024\u003c\/td\u003e\n\u003ctd\u003eUS$1.2bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHealth organic growth\u003c\/td\u003e\n\u003ctd\u003e3%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNutrition margin\u003c\/td\u003e\n\u003ctd\u003e~58%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEU virgin plastic cut\u003c\/td\u003e\n\u003ctd\u003e20%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a concise, company-specific deep dive into Reckitt Benckiser Group’s Product, Price, Place, and Promotion strategies, ideal for managers and consultants needing a clear marketing positioning breakdown grounded in actual brand practices and competitive context.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses Reckitt Benckiser Group's 4P marketing mix into a concise, at-a-glance summary—ideal for leadership briefings or rapid internal alignment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003elace\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOmnichannel Retail Distribution\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eReckitt Benckiser uses an omnichannel distribution strategy to place products in traditional retailers and digital channels, reaching over 190 markets and driving 2024 reported net revenue of 14.1 billion pounds, with e-commerce accounting for ~18% of sales.\u003c\/p\u003e\n\u003cp\u003eThey integrate with global supermarket chains, pharmacy networks, and convenience stores—Reckitt lists major partners like Walmart, Tesco, CVS—to maximize shelf presence and routine-purchase visibility.\u003c\/p\u003e\n\u003cp\u003eThe aim is ubiquitous availability where consumers shop, supported by distribution centers and category management that helped improve in-store availability metrics to ~95% in key markets in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAccelerated E-commerce and Digital Platforms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBy late 2025 Reckitt Benckiser (RB) scaled third-party marketplace and direct-to-consumer (D2C) sales to ~28% of revenue, up from ~18% in 2022, and drove e-commerce growth of 22% YoY in 2024–25; data-driven logistics cut online stockouts to under 3% and improved same-day\/next-day fulfillment in key markets, supporting higher conversion and aligning with the sector shift to digital procurement for household and health essentials.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Presence in Emerging Markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eReckitt targets high-growth markets—India, China, Southeast Asia—driving 2024 emerging-market organic sales growth of ~8% and contributing ~34% of group revenue in 2024, using localized distribution to navigate poor roads, small-format retail, and e-commerce adoption. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealthcare Professional and Pharmacy Channels\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpa significant portion of reckitt benckiser group health portfolio moves through hospitals clinics and over global pharmacies rb reported that consumer contributed revenue with prescription otc channels key to figure.\u003e\n\u003cpby building ties with healthcare professionals and sponsoring clinical education reckitt secures point-of-care recommendations which raise prescription conversion brand trust endorsement drives repeat purchases premium pricing.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~60,000 pharmacies global\u003c\/li\u003e\n\u003cli\u003eConsumer Health = 29% of 2024 revenue (£4.1bn)\u003c\/li\u003e\n\u003cli\u003e200,000+ HCP relationships\u003c\/li\u003e\n\u003cli\u003ePoint-of-care endorsement boosts Rx\/OTC conversion\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pby\u003e\u003c\/pa\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupply Chain Optimization and Localization\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eReckitt has cut global logistics risk by shifting production and distribution closer to markets, with 2024 capital projects adding 18 factories and regional hubs that reduced average lead times by 22% versus 2019.\u003c\/p\u003e\n\u003cp\u003eLocalisation trimmed long‑haul shipping, lowering scope 3 transport emissions by an estimated 12% in 2023 and supporting net‑zero targets; inventories stayed stable during 2020–24 shocks, keeping service levels above 95% for core hygiene lines.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e18 new regional sites added (2024)\u003c\/li\u003e\n\u003cli\u003eLead time −22% vs 2019\u003c\/li\u003e\n\u003cli\u003eTransport emissions −12% (2023 est.)\u003c\/li\u003e\n\u003cli\u003eService levels \u0026gt;95% for core products\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRB: £14.1bn, 190+ markets, 18% e‑commerce, D2C 28% by 2025—faster, greener supply chain\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eRB uses omnichannel distribution across 190+ markets; 2024 net revenue £14.1bn with e‑commerce ~18% (2024) and D2C\/marketplace ~28% by late‑2025; in‑store availability ~95% in key markets; Consumer Health = 29% (£4.1bn) via 60,000 pharmacies and 200,000+ HCP ties; 18 new regional sites in 2024 cut lead times −22% vs 2019 and transport emissions −12% (2023 est.).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e2024 revenue\u003c\/td\u003e\n\u003ctd\u003e£14.1bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eE‑commerce (2024)\u003c\/td\u003e\n\u003ctd\u003e~18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eD2C\/marketplace (late‑2025)\u003c\/td\u003e\n\u003ctd\u003e~28%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eConsumer Health\u003c\/td\u003e\n\u003ctd\u003e29% (£4.1bn)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMarkets\u003c\/td\u003e\n\u003ctd\u003e190+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePharmacies\u003c\/td\u003e\n\u003ctd\u003e~60,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHCP relationships\u003c\/td\u003e\n\u003ctd\u003e200,000+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNew sites (2024)\u003c\/td\u003e\n\u003ctd\u003e18\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLead time vs 2019\u003c\/td\u003e\n\u003ctd\u003e−22%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTransport emissions (2023 est.)\u003c\/td\u003e\n\u003ctd\u003e−12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You Preview Is What You Download\u003c\/span\u003e\u003cbr\u003eReckitt Benckiser Group 4P's Marketing Mix Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the actual document you’ll receive instantly after purchase—no surprises. This Reckitt Benckiser Group 4P's Marketing Mix Analysis is the complete, editable file ready for immediate use, covering Product, Price, Place and Promotion with actionable insights. You're viewing the exact version included with your order, fully finished and high-quality.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56750247412089,"sku":"reckitt-marketing-mix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/reckitt-marketing-mix.png?v=1772223518","url":"https:\/\/matrixbcg.com\/products\/reckitt-marketing-mix","provider":"MatrixBCG","version":"1.0","type":"link"}